Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integra Flowable for Diabetic Foot Ulcers
NCT01108263Phase 4Terminated
- Sponsor
- Georgetown University
- Start
- Jun 2010
- Primary completion
- Aug 2011
- Modality
- Fragment-Derived Small Molecules, Device-based Delivery, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Integra Flowable Matrix in diabetic foot ulcer (DFU), sponsored by Georgetown University. Started Jun 2010; status: terminated.
02
Drugs
Integra Flowable Matrix
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01108263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108263.